Introduction {#s1}
============

Clinically, intraocular pressure (IOP) remains the only proven modifiable risk factor for primary open-angle glaucoma (POAG).[@R1] Increment in IOP may occur in the absence of identified disease as a part of ageing. There is controversy regarding the biological change in IOP with age. Recent research suggests there may be ethnic/racial differences in IOP patterns. In these prospective studies, IOP decreased in Asian populations,[@R2] whereas it remained fairly steady over time in Caucasians[@R9] and African-origin persons.[@R10]

Direct comparison among these ethnic/racial populations is particularly challenging. First, there have been no longitudinal IOP data on Asian groups other than East Asians (Japanese,[@R3] Koreans[@R2] and Chinese[@R5]). Generally speaking, Japanese are considerably more prone to developing normal tension glaucoma, whereas Chinese persons are more at risk of developing primary angle-closure glaucoma.[@R12] Thus, it is unclear if the natural history of IOP among East Asians can reflect that of other Asian groups, who tend to be mostly affected by POAG.[@R13] Second, studies on Caucasians[@R9] and Africans[@R10] have used the Goldmann applanation tonometry (GAT), whereas majority of studies on Asians[@R2] used non-contact tonometer, except for the Japanese study.[@R3] Third, although Nakano and colleagues[@R3] have used the gold standard GAT, their study consisted almost exclusively of healthy men who were in their young adulthood, whereas Western and African studies were performed on community-dwelling older adults. Thus, conclusions from the Japanese data must be confined to younger men and should be interpreted with caution for older adults and women. Overall, it remains unclear whether the observed variations among these populations were due to ethnic/racial difference or the discrepancies in study designs and IOP measurement techniques.

It is well known that the aqueous humour production and outflow facility alters with age,[@R14] and IOP measurements using the GAT on a representative group of older Asian populations are lacking. At the same time, however, the incidences of various systemic diseases and use of systemic medications[@R15] increase sharply in those over about 40 years. Given the consistent relationship between systemic blood pressure (BP) levels and hypertension with IOP,[@R17] it is clear that the influence of age and systemic BP on IOP is complex and cannot be examined in isolation. In an effort to resolve some of these issues, we investigated the biological effect of ageing on IOP and risk factors for such changes during a 6-year period in a South East Asian population of Singaporean Malays and Indians aged ≥40 years. We hypothesised that there will a biological effect of ageing on IOP, and there will be a synchronous change in IOP in the presence of change in systemic BP that often accompany treatment for hypertension.

Methods {#s2}
=======

Study population {#s2-1}
----------------

The Singapore Malay Eye study (SiMES)[@R18] and Singapore Indian Eye Study (SINDI)[@R19] are population-based studies of Malay and Indian adults. Baseline examinations were performed during 2004--2006 for 3280 Malays and 2007--2009 for 3400 Indians. An age-stratified (by 10-year age groups) random sampling was used to select Malays and Indians, aged ≥40 years living across the southwestern part of Singapore. The number of selected subjects was 4168 Malays and 4497 Indians. Of these, 3280 Malays and 3400 Indians participated in the study.

Six-year follow-up examinations were conducted during 2011--2013 for Malays (SiMES-2)[@R20] and 2007--2009 for Indians (SINDI-2).[@R21] Of the 3280 Malays seen at baseline, 415 had died, 229 were terminally ill, mobility or cognitively impaired or had moved away, and 1901 Malays (response rate 72%) were re-examined.[@R20] Of the 3400 Indians seen at baseline, 201 had died, 285 were terminally ill, mobility or cognitively impaired or had moved away and 2200 Indians (response rate 75%) were re-examined.[@R21]

Both Malay and Indian participants observed at 6-year follow-up examinations were younger (p\<0.001), tended to be female (p=0.001), had lower systolic BP (SBP) (p\<0.001) than non-participants. However, Malay participants had a lower diastolic BP (DBP) (79.4±11.0 mm Hg vs 80.4±11.7 mm Hg; p=0.017) than their non-participants, whereas there was no DBP difference between the Indian participants and Indian nonparticipants (77.7±10.1 mm Hg vs 77.5±10.6 mm Hg; p=0.51).

Approval for conducting baseline and follow-up studies, including the consent procedure, was obtained from the Singapore Eye Research Institute Institutional Review Board, and all study procedures adhered to recommendations of the Declaration of Helsinki. Written Informed consent was obtained from all participants.

Examination procedures {#s2-2}
----------------------

Both Malay and Indian participants underwent similar clinical and ocular examination in the Singapore Eye Research Clinic. SBP and DBP were measured using a digital automatic BP monitor (Dinamap model Pro Series DP110X-RW, Milwaukee, Wisconsin,  USA), after subjects were seated for at least 5 min. BP was measured twice, with 5 min apart. A third measurement was taken if previous two SBP readings differed by \>10 mm Hg or the DBP by \>5 mm Hg. The BP of the participant was defined as the mean between the two closest readings.

GAT was used to measure IOP (Haag-Streit, Koeniz, Switzerland) before pupil dilation.[@R22] A single drop of topical anaesthesia (amethocaine hydrochloride 0.5%) was administered into the inferior conjunctival sac and a dry strip of fluorescein stained the cornea. One reading was taken from each eye and recorded. If the reading was \>21 mm Hg, then a repeat reading was taken, and the second reading was used.

Other measurements {#s2-3}
------------------

A detailed interviewer-administered questionnaire was used to collect demographic data, lifestyle risk factors (eg, smoking), medical history (eg, hypertension and diabetes), ocular history (eg, glaucoma) and medication use. Ethnicities were set by the Singapore census,[@R23] and participants were given a choice to be interviewed in English, Malay or Tamil. Blood samples were collected for analysis of haemoglobin A1c (HbA1c) and plasma glucose. Hypertension was defined as SBP ≥140 mm Hg and/or DBP ≥90 mm Hg and/or self-reported physician diagnosed hypertension and/or history of antihypertensive medication. Newly diagnosed hypertensive were defined as individuals having hypertension at follow-up visit but were normotensive at baseline visit. Diabetes was defined as HbA1c ≥6.5%, non-fasting plasma glucose ≥11.1 mmol/L, self-reported physician diagnosed diabetes or history of glucose-lowering medication. Participants' height was measured in centimetres using a wall-mounted measuring tape, and weight was measured in kilograms using a digital scale (SECA, model 782 2321009, Germany). Smoking status was defined as those never smoked, current smokers and past smokers. Body mass index (BMI) was calculated as body weight (in kilograms) divided by body height (in metres) squared.

Statistical analyses {#s2-4}
--------------------

All baseline values were defined as obtained during baseline examinations. Primary outcome was change in IOP, defined as the difference between the 6-year IOP and the baseline IOP (ie, IOP at 6-year visit *minus* IOP at baseline). To compare the characteristics of participants among groups, one-way analysis of variance test was performed for continuous variables, and χ^2^ test was used for categorical variables. There was a strong correlation between the intereye IOPs in the baseline (r=0.893, p\<0.001) and follow-up (r=0.891, p\<0.001) IOPs. GEE is able to appropriately account for intereye correlation as well as to maximise power and precision of the dataset.[@R24] Association between ocular and systemic factors (independent variables) with changes in IOP (dependent variable) were assessed using multivariate linear regression models with generalised estimating equations that accounted for intereye correlation. In addition to age, gender, ethnicity and baseline IOP, factors with p\<0.10 in the first model were included in the multivariate model. Hypertension status was coded as a set of indicator variables with normotension as the reference group. Data were analysed with statistical software (STATA, V.13.1).

Results {#s3}
=======

Of the 4101 participants who participated at the baseline and 6-year follow-up examinations, we excluded 188 participants (376 eyes) with a history of glaucoma diagnosis or glaucoma surgery or medication because their IOP may be biassed.[@R26] We further excluded 701 participants (1402 eyes) who had undergone cataract surgery because pseudophakic eyes tended to have lower IOP.[@R22] We also excluded 24 participants on the basis of missing IOP and BP clinical variables ([figure 1](#F1){ref-type="fig"}). Of the remaining 3188 persons, 484 (15%) developed hypertension at 6-year follow-up.

![Identification of eligible participants from the Singapore Malay Eye study and Singapore Indian Eye study observed at both baseline and 6-year examinations. Of the 4101 participants who participated at the baseline and follow-up examinations, 3188 were included in the analysis, of which 484 (15%) developed hypertension at 6-year follow-up. BP, blood pressure; IOP, intraocular pressure.](bjophthalmol-2018-311897f01){#F1}

[Table 1](#T1){ref-type="table"} shows the baseline clinical characteristics of participants stratified by hypertensive status. Mean age and SD of participants was 54.4±8.5 years, 53% were female and 48% were Malays. Over the 6-year period, systemic BP increased in those who remained normotensive as well as those who developed hypertension, whereas it decreased in those who remained hypertensive (p\<0.001). At baseline, the mean IOP was 15.4±3.0 mm Hg and was lowest for those who were normotensive compared with those with hypertension (14.9 mm Hg vs 15.4--15.7 mm Hg; p\<0.001). Mean IOP decreased by −0.4 to −0.8 mm Hg for most groups; in contrast, IOP changes were symmetric around zero for individuals who were newly diagnosed with hypertension (subgroup 2: 0.0±3.1 mm Hg; p=0.299).

###### 

Characteristics of participants by hypertensive status

  Subgroups                         Total        Subgroup 1   Subgroup 2   Subgroup 3    Subgroup 4    P values\*
  --------------------------------- ------------ ------------ ------------ ------------- ------------- ------------
  Number of participants, %         3188 (100)   907 (28)     484 (15)     1656 (52)     141 (5)       
  Number of eyes                    6376         1814         968          3312          282           
  Age, years                        54.4±8.5     50.1±6.5     52.5±7.3     57.5±8.6      52.7±8.2      \<0.001
  Gender, female                    1678 (53)    470 (52)     261 (54)     883 (53)      64 (45)       0.278
  Ethnicity                                                                                            
    Malays                          1519 (48)    365 (40)     207 (43)     871 (53)      76 (54)       \<0.001
    Indians                         1669 (52)    542 (60)     277 (57)     785 (47)      65 (46)       
  Smoking Status                                                                                       
    Never                           2235 (70)    628 (69)     331 (69)     1188 (72)     88 (63)       \<0.001
    Current smoker                  534 (17)     189 (21)     93 (19)      215 (13)      34 (26)       
    Past smoker                     415 (13)     88 (10)      60 (12)      251 (15)      16 (11)       
  Body mass index, kg/m^2^          26.4±4.6     25.0±4.1     26.2±4.4     27.3±4.7      26.0±4.7      \<0.001
  Diabetes                          915 (30)     125 (16)     122 (26)     639 (40)      29 (21)       \<0.001
  HbA1c (%)                         6.3±1.4      5.8±0.8      6.3±1.6      6.5±1.4       6.2±1.2       \<0.001
  Blood pressure, mm Hg                                                                                
    Systolic                        137.2±21.2   119.2±10.6   127.5±8.6    149.8±20.14   139.0±13.7    \<0.001
    Diastolic                       78.9±10.6    72.7±7.0     75.9±7.1     83.0±11.3     80.9±9.0      \<0.001
  Change in blood pressure, mm Hg                                                                      
    Systolic                        0.2±19.6†    2.9±11.2†    14.0±16.2†   −4.4±22.0†    −10.3±13.8†   \<0.001
    Diastolic                       −1.2±10.5†   1.0±6.8†     5.0±8.9†     −4.0±11.5†    −4.4±8.9†     \<0.001
  Antihypertensive medications                                                                         
    Neither examinations            1782 (56)    887 (100)    341 (71)     437 (26)      117 (85)      \<0.001
    Baseline only                   141 (5)      --           --           121 (7)       20 (15)       
    Follow-up only                  500 (16)     --           139 (29)     361 (22)      --            
    Both examinations               737 (23)     --           --           737 (45)      --            
  IOP, mm Hg                        15.4±3.0     14.9±2.9     15.4±2.9     15.7±3.0      15.5±2.9      \<0.001
  Change in IOP, mm Hg              −0.5±3.1†    −0.4±3.0†    0.0±3.1      −0.6±3.2†     −0.8±3.1†     \<0.001

Data are mean±SD or number (%), as appropriate.

\*Test for differences between hypertensive groups, based on one-way analysis of variance test for continuous variables and with χ^2^ tests for categorical variables.

†P\<0.05. Test for differences in continuous variables between baseline versus follow-up, based on Wilcoxon matched-pairs signed-ranks test.

IOP, intraocular pressure.

Factors associated with 6-year IOP change were explored by linear regression modelling ([table 2](#T2){ref-type="table"}). The age-adjusted, gender-adjusted, ethnicity-adjusted and baseline IOP-adjusted analyses found female gender, ethnicity, baseline IOP, BMI, diabetes, HbA1c and hypertension to be associated with IOP change (model 1, [table 2](#T2){ref-type="table"}). Multivariable analysis showed that changes in IOP were negatively associated with age (β=−0.07, 95% CI −0.13 to −0.01) and baseline IOP (β=−0.69, 95% CI −0.71 to −0.66), and positively associated with female gender (β=0.35, 95% CI 0.12 to 0.58), Indian ethnicity (β=0.70, 95% CI 0.52 to 0.89), BMI (β=0.02, 95% CI 0.01 to 0.04), diabetes (β=0.27, 95% CI 0.06 to 0.49), hypertension (normotensive as reference group; newly developed hypertensive (β=0.67, 95% CI 0.39 to 0.95) and chronic hypertensive (β=0.46, 95% CI 0.22 to 0.70; model 2, [table 2](#T2){ref-type="table"})). No interactions between age and gender or ethnicity were noted (p for interaction=0.854 for gender; 0.144 for ethnicity).

###### 

Association with changes in intraocular pressure (IOP) assessed using multivariate linear regression models with generalised estimating equations (n=3188 persons; 6376 eyes)

  Characteristics                                                        Change in IOP (mm Hg)        
  ---------------------------------------------------------------------- ---------------------------- ----------------------------
  Age, per 5 years                                                       −0.02 (−0.07 to 0.03)        −0.07 (−0.13 to −0.01)\*
  Gender, female                                                         0.46 (0.29 to 0.64)\*\*      0.35 (0.12 to 0.58)\*
  Ethnicity                                                                                           
    Malays                                                               Reference                    Reference
    Indians                                                              0.69 (0.51 to 0.86)\*\*      0.70 (0.52 to 0.89)\*\*
  Baseline IOP, mm Hg                                                    −0.68 (−0.70 to −0.65)\*\*   −0.69 (−0.71 to −0.66)\*\*
  Smoking status                                                                                      
    Never                                                                Reference                    
    Current smoker                                                       −0.22 (−0.51 to 0.07)        --
    Past smoker                                                          −0.14 (−0.46 to 0.19)        --
  Body mass index, kg/m^2^                                               0.04 (0.02 to 0.06)\*\*      0.02 (0.01 to 0.04)\*
  Diabetes                                                               0.40 (0.19 to 0.60)\*\*      0.27 (0.06 to 0.49)\*
  HbA1c (%)                                                              0.09 (0.03 to 0.16)\*        0.05 (−0.02 to 0.12)
  Hypertensive status                                                                                 
    Subgroup 1: normotensive at baseline and follow-up                   Reference                    Reference
    Subgroup 2: normotensive at baseline and hypertensive at follow-up   0.76 (0.49 to 1.04)\*\*      0.67 (0.39 to 0.95)\*\*
    Subgroup 3: hypertensive at baseline and follow-up                   0.60 (0.38 to 0.82)\*\*      0.46 (0.22 to 0.70)\*\*
    Subgroup 4: hypertensive at baseline and normotensive at follow-up   0.22 (−0.20 to 0.63)         0.18 (−0.24 to 0.60)

\*Denotes P\<0.05.

\*\*Denotes P\<0.001.

†Model 1 adjusted for age, gender, ethnicity and IOP.

‡Model 2 adjusted for age, gender, ethnicity, IOP, body mass index, diabetes and hypertensive. When HbA1c was assessed as an exposure, diabetes was removed from the model.

--, data were intentionally omitted; HbA1c, haemoglobin A1c.

In separate models that considered baseline SBP or DBP rather than hypertension, 6-year changes in IOP were related to higher baseline SBP (β=0.20, 95% CI 0.14 to 0.26) and DBP (β=0.33, 95% CI 0.22 to 0.44), as well as with 6-year increases in SBP (β=0.27, 95% CI 0.21 to 0.33) or DBP (β=0.52, 95% CI 0.41 to 0.63; [table 3](#T3){ref-type="table"}). That is, for every 10 mm Hg increase in SBP or DBP, there was a 0.27 mm Hg or 0.52 mm Hg increase in IOP, respectively. Further analysis stratified by hypertensive status showed that such trends of increasing IOP as levels of SBP or DBP increased were mostly consistent across all groups ([table 3](#T3){ref-type="table"}). Only baseline use of antihypertensive medications was associated with increase in IOP, whereas use of medications at follow-up only was not associated with change in IOP.

###### 

Association with changes in intraocular pressure (IOP) by hypertensive status assessed using multivariate linear regression models with generalised estimating equations

  Characteristics                  Change in IOP (mm Hg)                                                         
  -------------------------------- ------------------------- ------------------------- ------------------------- --------------------------
  Model with SBP                                                                                                 
    Baseline SBP, per 10 mm Hg     0.20 (0.14 to 0.26)\*\*   0.31 (0.12 to 0.50)\*     0.16 (0.09 to 0.24)\*\*   −0.04 (−0.55 to 0.45)
    Change in SBP, per 10 mm Hg    0.27 (0.21 to 0.33)\*\*   0.31 (0.20 to 0.57)\*\*   0.24 (0.17 to 0.31)\*\*   0.26 (−0.18 to 0.71)
    Antihypertensive medications                                                                                 
     Neither examinations          Reference                 --                        Reference                 Reference
     Baseline only                 0.43 (−0.01 to 0.97)      --                        0.62 (0.02 to 1.23)\*     −1.34 (−2.81 to 0.13)
     Follow-up only                −0.01 (−0.23 to 0.27)     --                        −0.04 (−0.36 to 0.28)     --
     Both examinations             0.02 (−0.23 to 0.27)      --                        0.01 (−0.29 to 0.30)      --
  Model with DBP                                                                                                 
    Baseline DBP, per 10 mm Hg     0.33 (0.22 to 0.44)\*\*   0.29 (0.01 to 0.59)\*     0.27 (0.14 to 0.41)\*\*   0.14 (−0.53 to 0.81)
    Change in DBP, per 10 mm Hg    0.52 (0.41 to 0.63)\*\*   0.57 (0.27 to 0.87)\*\*   0.45 (0.32 to 0.58)\*\*   0.67 (0.06 to 1.28)\*
    Antihypertensive medications                                                                                 
     Neither examinations          Reference                 --                        Reference                 Reference
     Baseline only                 0.47 (−0.06 to 1.01)      --                        0.60 (0.01 to 1.21)\*     −1.12 (−2.22 to −0.02)\*
     Follow-up only                0.05 (−0.22 to 0.33)      --                        −0.07 (−0.39 to 0.25)     --
     Both examinations             0.06 (−0.18 to 0.31)      --                        −0.03 (−0.32 to 0.26)     --

Subgroups refer to hypertensive status: subgroup 1: normotensive at baseline and follow-up; subgroup 2: normotensive at baseline and hypertensive at follow-up; subgroup 3: hypertensive at baseline and follow-up; and subgroup 4: hypertensive at baseline and normotensive at follow-up.

\*Denotes P\<0.05.

\*\*Denotes P\<0.001.

†Model with SBP (or DBP) adjusted for age, gender, ethnicity, IOP, body mass index, diabetes, SBP (or DBP), change in SBP (or change in DBP) and antihypertensive medications.

‡Model with SBP (or DBP) adjusted for age, gender, ethnicity, IOP, body mass index, diabetes, SBP (or DBP) and change in SBP (or change in DBP).

--, data were intentionally omitted; DBP, diastolic blood pressure; IOP, intraocular pressure; SBP, systolic blood pressure.

We next considered the effect of various antihypertensive medication classes on hypertensive participants who received antihypertensive medications only during follow-up ([online supplementary file 1](#SP1){ref-type="supplementary-material"}). These were 139 participants from subgroup 2 and 361 from subgroup 3. After adjusting for age, gender, ethnicity, IOP, BMI, diabetes, SBP and change in SBP, lower IOP was found in participants taking β-blockers (β=−0.55, 95% CI −0.96 to −0.13; p=0.01). The association with β-blockers remained significant when adjustments were made for DBP (β=−0.50, 95% CI −0.93 to −0.07). However, change in IOP was not significantly associated with participants on other medication classes ([online supplementary table 1](#SP1){ref-type="supplementary-material"}; p\>0.05). In a separate model that considered β-blockers rather than use of antihypertensive medications ([online supplementary table 2](#SP1){ref-type="supplementary-material"}), 6-year changes in IOP were related with 6-year increases in SBP (β=0.27, 95% CI 0.17 to 0.31) or DBP (β=0.33, 95% CI 0.06 to 0.60).
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[Figure 2](#F2){ref-type="fig"} further illustrates the trend observed between age group and BP increments with changes in IOP as seen in the multivariable linear regression model. Individuals who were older (p trend=0.012; [figure 2A](#F2){ref-type="fig"}) had a larger decrease in IOP. It was −0.36±0.16 mm Hg for persons 40--49 years, −0.51±0.14 mm Hg for those 50--59 years, −0.55±0.22 mm Hg for those 60--69 years and −0.94±0.40 mm Hg for those 70 years or older. In terms of BP increments, there was a mean decrease of −0.39±0.14 mm Hg in IOP over the 6-year interval for those whose SBP was within 10 mm Hg of their baseline BP compared with a decrease of −0.04±0.18 mm Hg for those whose SBP increased by 10 mm Hg and a decrease of −1.18±0.20 mm Hg in IOP for those whose SBP decreased by 10 mm Hg or more (p trend \<0.001; [figure 2B](#F2){ref-type="fig"}). Values for change in IOP for similar changes in DBP were −0.38±0.12, 0.08±0.26 and −1.35±0.26 mm Hg, respectively.

![Distribution of change in IOP stratified by (A) age groups and (B) blood pressure increments. \*Data and p values shown for age groups are after adjustment for age group, gender, ethnicity, IOP, smoking, body mass index, diabetes and hypertensive status. †Data and p values shown for change in blood pressure increments are after adjustment for age, gender, ethnicity, IOP, smoking, body mass index, diabetes, SBP (or DBP), change in SBP (or change in DBP) and antihypertensive medications. DBP, diastolic blood pressure; IOP, intraocular pressure; SBP, systolic blood pressure.](bjophthalmol-2018-311897f02){#F2}

We evaluated the effects of timing variations (eg, morning of the baseline visit and evening follow-up or vice versa) or seasonal variations (eg, warmer months at baseline vs cooler months at follow-up) on IOP measurements. No significant effects were found (data not shown).

Discussion {#s4}
==========

After 6 years of follow-up, normal ageing is associated with a reduced IOP, while individuals who were women, of Indian ethnicity, with diabetes, those having higher BMI and greater change in systolic and diastolic BP are associated with greater change in IOP in these Malay and Indian populations living in Singapore. Understanding changes in IOP over time and their related factors may be relevant when managing patients with glaucoma who are also receiving treatment for systemic comorbidities. To our knowledge, our study is the first epidemiological study on South East Asians that assessed the biological effects of IOP and the factors affecting its trend by using the same methodology to collect data over the 6 years.

There is little doubt that IOP decreased with ageing in Asians ([table 2](#T2){ref-type="table"} and [figure 2A](#F2){ref-type="fig"}). Data from our study and previous work on East Asian populations[@R2] support this relationship. In vast majority of individuals, there was a minimal decrease of 0.4--0.6 mm Hg in IOP over the 6 years; in contrast, IOP changes were symmetric around zero for individuals who were newly diagnosed with systemic hypertension, who correspondingly had the greatest increase in BP. We can better appreciate the neutralising effect of systemic hypertension on the biological ocular hypotensive effect of ageing when we stratified our participants based on the recency of hypertensive status. However, none of the Caucasian and African studies have stratified the participants based on the recency of systemic hypertension onset, typically signified by a substantial increase in BP; it is conceivable that the hypotensive effect of ageing may have been overshadowed or nullified by the ocular hypertensive effect of systemic hypertension and IOP therefore increases with age or remains unchanged, respectively.

Information on the natural history of IOP in Asian population is of scientific interest as it may uncover important insights into the pathogenesis and risk for POAG. One long-standing hypothesis that has emerged to explain the greater burden of POAG in the elderly stresses the importance of age-related elevation of IOP, where the elevated IOP directly compresses the optic nerve head, thereby distorting the lamina cribrosa and interrupting the axoplasmic flow, ultimately resulting in the death of the retinal ganglion cells.[@R28] The decrease in IOP with advancing age, although modest, clearly does not support the notion that the age-related nature of POAG is mediated via an increase in IOP with age. Rather, the increase of prevalence of POAG with age may be explained by a greater susceptibility of the optic nerve head to IOP or other non-IOP-related risk factors.[@R29] Unfortunately, our understanding of the mechanism on the biologically decreasing trend of IOP is far from complete. The most likely explanation may be the age-related decline in aqueous humour production,[@R30] partially counteracted by the increase in aqueous outflow resistance.[@R14] This decrease of aqueous humour production may be more pronounced in Asians than other populations, although this hypothesis needs confirmation in future studies.

Glaucoma-related changes to IOP levels can be confounded by normal ageing as well as systemic comorbidities. We found that individuals who have diabetes, were hypertensives, with higher BMI and higher SBP and DBP levels exhibited higher IOP levels, adding another layer of complexity to determining the 'true' IOP of the eye. Similarly, other longitudinal studies have shown that the IOP is influenced by systemic parameters such as diabetes,[@R9] BMI[@R3] and BP levels.[@R3] Elevated IOP is a common cause of referral to eye care services, and current care model requires the regular monitoring of high-risk suspects.[@R31] Our findings indicate that individuals without evidence of glaucoma may potentially be at risk of higher IOP, depending on their control of BP. In view of the rising burden of systemic hypertension in people worldwide,[@R32] together with the compulsory referral of high-risk suspects, uncontrolled systemic hypertension can lead to an increasing and unnecessary referrals for ophthalmological investigations, significantly an impact to the quality and costs of healthcare services.

The mechanism underlying the relation between BP and IOP is unclear based on the present data. However, it may be related to the increase of ocular perfusion pressure that is often associated with an increased aqueous production. Linear relationship between aqueous humour production and ciliary blood flow have been reported until above a threshold level of perfusion.[@R33] Alternatively, the dependence of IOP on BP may be related to the increase in choroidal volume with the elevation of BP. Studies have observed an ocular pressure--volume relationship that is dependent on the level of the mean arterial pressure.[@R34] Another plausible explantion is that the atherosclerotic processes have led to the increase in BP, thereby causing an increase in the aqueous outflow resistance. Higher levels of IOP has been shown to be significantly associated with the presence of coronary artery calcium, independent of conventional cardiovascular risk factors.[@R36] In the present study, however, treatment of systemic hypertension was associated with normalisation of the IOP--BP relation, indicating that the association is rather dependent on the actual BP level than on the presence of hypertension. Finally, we cannot exclude the possibility of BP-lowering drugs having a direct pharmacological effect on either outflow resistance or aqueous humour production. We[@R15] and others[@R16] have found that participants using systemic β-blocker, a commonly prescribed BP-lowering drug, had lowered IOP. Unfortunately, the sample size in the current study was inadequate for a subgroup analysis, based on various systemic antihypertensive agents.

Study strengths and limitations {#s4-1}
-------------------------------

Strengths of the study included population-based study, high participation rate (follow-up of 72% of survivors) and availability of two major Asian ethnic groups with similar standardised study methodology. The use of gold standard GAT equipment further strengthened the study. However, our study had a few limitations. Patients lost to follow-up were older, had higher systemic BP and had higher prevalence of hypertension. These could have underestimated the relation between change in BP and change in IOP. Second, misclassification of hypertension status as derived from the clinical examinations may have occurred because the classification was based, in part, on two measurements of the BP during a single examination. When we analysed the data for hypertension status based on the follow-up examination findings, we found that approximately 4% of the participants who were initially classified as hypertensive were now deemed normotensive during the follow-up. Lastly, only one IOP measurement was taken in each eye at each visit, which is less accurate than having multiple IOP measurements.

In conclusion, after 6-year follow-up, our population-based study of Malay and Indian adults living in Singapore revealed that IOP shows a biological decrease with age. We have also found that changes in IOP are directly and significantly associated with changes in systemic BP, particularly in subjects with established systemic hypertension. Our finding highlights the importance of BP control in patients with glaucoma as this will result in the lowering of IOP over time. Given that high IOP is a major glaucoma risk factor, it underscores the importance of controlling BP in older adults, where glaucoma burden is especially high.
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